ASKAT INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 19236
 
 
 
C07D HETEROCYCLIC COMPOUNDS 14148
 
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 346
 
 
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 3135
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 293

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0360,764 USE OF EP4 RECEPTOR ANTAGONISTS IN THE TREATMENT OF CARTILAGE DISEASEAug 04, 17Dec 21, 17[A61K, C07D]
2017/0253,595 SELECTIVE EP4 RECEPTOR ANTAGONISTIC SUBSTANCE FOR TREATMENT OF CANCERMay 23, 17Sep 07, 17[A61K, C07D, C07C]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9688674 Selective EP4 receptor antagonistic substance for treatment of cancerNov 19, 14Jun 27, 17[A61K, C07D, C07C]
9561210 Therapeutic agent for ocular diseaseMar 31, 14Feb 07, 17[A61K, C07D]
9457084 Use of EP4 receptor antagonists in the treatment of IL-23 mediated diseasesFeb 22, 11Oct 04, 16[A61K, A01N, C07D]
9447065 Pharmaceutical compositionOct 18, 12Sep 20, 16[A61K, B82Y, C07D, C08B, C08L]
9447066 Salts and crystal formsJan 06, 14Sep 20, 16[A61K, C07D, C07C]
8980922 5-HT4 receptor agonists for the treatment of dementiaFeb 14, 11Mar 17, 15[A61K, C07D, A61P]
8921391 Selective EP4 receptor antagonistic substance for treatment of cancerApr 22, 10Dec 30, 14[A61K, A01N, C07D, C07C]
8653063 N-substituted saturated heterocyclic sulfone compounds with CB2 receptor agonistic activityJan 22, 10Feb 18, 14[A61K, C07D, A61P]
7960407 Crystal forms of an imidazole derivativeMar 01, 06Jun 14, 11[A61K, C07D, A61P]
7776885 Benzimidazolone compounds having 5-HT4 receptor agonistic activitySep 02, 04Aug 17, 10[A61K, C07D]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0317,514 USE OF EP4 RECEPTOR ANTAGONISTS IN THE TREATMENT OF CARTILAGE DISEASEAbandonedMar 19, 14Nov 03, 16[A61K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.